2026年全球髂動脈支架市場報告

近年來，髂動脈支架市場經歷了顯著成長，預計將從2025年的10.9億美元成長到2026年的11.7億美元，複合年成長率為7.2%。過去幾年的成長可能歸因於多種因素，例如周邊動脈疾病盛行率的上升、人口老化、血管內治療方法的日益普及、醫院血管治療的擴展以及髂動脈病變診斷準確性的提高。

預計未來幾年髂動脈支架市場將強勁成長，到2030年市場規模將達到15億美元，複合年成長率（CAGR）為6.4%。預測期內的成長主要歸因於以下因素：對微創手術的需求不斷成長、文明病相關血管疾病發病率上升、介入性心臟病學服務覆蓋範圍擴大、新興經濟體醫療費用支出增加以及對早期血管介入治療的日益重視。預測期內的主要趨勢包括：微創外周介入治療的普及、對自膨式髂動脈支架的偏好日益成長、藥物釋放型支架和覆膜支架在複雜病變中的應用日益廣泛、門診和當日血管內治療的興起，以及髂動脈支架在嚴重和鈣化病變中的應用日益增多。

預計周邊動脈疾病發生率的不斷上升將推動髂動脈支架市場在不久的將來擴張。周邊動脈疾病（PAD）是一種血管疾病，其特徵是心臟和大腦以外的動脈狹窄或阻塞，通常由吸煙、老化、高血壓和糖尿病等因素引起。髂動脈置入術已成為治療方法PAD患者的有效方法，它能夠改善血流、緩解症狀並減少併發症，同時具有微創和高成功率的優點。例如，根據心血管血管造影術和介入學會（SCAI）2023年7月的數據，PAD每年影響800萬至1000萬美國人，預計到2050年這一數字將達到1900萬。因此，周邊動脈疾病盛行率的不斷上升是推動髂動脈支架市場成長的主要動力。

髂動脈支架市場的主要企業正致力於產品研發，例如iCast，以改善患者預後並降低併發症風險。 iCast覆膜支架系統代表了一種治療髂動脈阻塞性疾病的新方法，與傳統的裸金屬支架相比，它具有更優異的性能和更低的併發症風險。例如，2023年10月，Getinge公司開始在美國商業性其獲得FDA核准的iCast覆膜支架系統，用於治療髂動脈阻塞性疾病。這項進展凸顯了該公司致力於為美國醫療專業人員和醫院系統提供尖端產品和支持，以有效應對這一嚴重疾病的承諾。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球髂動脈支架市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧（AI）和自主人工智慧
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 微創周邊血管介入治療的普及率不斷提高
  • 自膨式髂動脈支架越來越受歡迎
  • 藥物釋放型支架和覆膜支架在複雜病變的應用日益廣泛
  • 過渡到門診和當日血管內治療
  • 擴大髂動脈支架在嚴重和鈣化病變的應用

第5章 終端用戶產業市場分析

• 醫院
• 門診護理設施
• 門診手術中心
• 專科心臟診所
• 血管外科中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球髂動脈支架市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球髂動脈支架市場規模、對比及成長率分析
• 全球髂動脈支架市場表現：規模與成長，2020-2025年
• 全球髂動脈支架市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 按類型
• 自動擴張型支架、球囊擴張型支架及其他類型
• 動脈病變
• 髂總動脈病變，嚴重鈣化病變
• 最終用戶
• 醫院、門診機構和其他最終用戶
• 依類型細分：自動擴張型支架
• 鎳鈦合金自動擴張型支架，聚合物塗層自動擴張型支架
• 按類型細分：球囊擴張型支架
• 裸金屬球囊擴張型支架，藥物釋放型球囊擴張型支架
• 按類型細分：其他類型
• 覆膜支架，混合支架

第10章 區域與國家分析

• 全球髂動脈支架市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球髂動脈支架市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 髂動脈支架市場：競爭格局及市場佔有率（2024 年）
• 髂骨支架市場：公司估值矩陣
• 髂動脈支架市場：公司概況
  • Cardinal Health Inc.
  • Abbott Laboratories
  • Medtronic Plc
  • Becton, Dickinson and Company
  • Boston Scientific Corporation

第37章：其他領先和創新企業

• B. Braun Melsungen AG, Terumo Corporation, WL Gore & Associates Inc, CR Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年髂動脈支架市場：提供新機會的國家
• 2030年髂動脈支架市場：充滿新機會的細分市場
• 2030年髂動脈支架市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Iliac stents are specialized medical devices crafted to address atherosclerosis in the iliac arteries, situated in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to widen and provide support to narrowed or obstructed arteries.

The primary types of iliac stents include self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical instruments utilized for treating narrowed or obstructed blood vessels in various parts of the body, including the coronary arteries, peripheral arteries, and other tubular structures. They are employed in the treatment of various artery lesions such as common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. These stents are utilized by a range of end-users including hospitals, outpatient facilities, and others.

Tariffs have created cost pressures and supply chain challenges in the iliac stent market by increasing prices of imported raw materials, metallic alloys, and precision medical components used in stent manufacturing. These impacts have affected production timelines and pricing strategies, particularly for balloon-expandable and drug-eluting stents, with Asia-pacific and north america experiencing the most disruption due to reliance on cross-border medical device trade. Hospitals and outpatient facilities have faced higher procurement costs, influencing purchasing decisions and reimbursement dynamics. However, tariffs have also encouraged local manufacturing, regional sourcing, and domestic capacity expansion, supporting supply chain resilience and long-term market stability.

The iliac stent market research report is one of a series of new reports from The Business Research Company that provides iliac stent market statistics, including iliac stent industry global market size, regional shares, competitors with a iliac stent market share, detailed iliac stent market segments, market trends and opportunities, and any further data you may need to thrive in the iliac stent industry. This iliac stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iliac stent market size has grown strongly in recent years. It will grow from $1.09 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising prevalence of peripheral artery disease, growing aging population, increased adoption of endovascular procedures, expansion of hospital-based vascular care, improved diagnosis of iliac artery lesions.

The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive treatments, increasing incidence of lifestyle-related vascular disorders, expanding access to interventional cardiology services, rising healthcare expenditure in emerging economies, increasing focus on early vascular intervention. Major trends in the forecast period include rising adoption of minimally invasive peripheral interventions, increasing preference for self-expandable iliac stents, growing use of drug-eluting and covered stents in complex lesions, shift toward outpatient and day-care endovascular procedures, expansion of iliac stent usage in severe and calcified lesions.

The increasing incidence of peripheral artery diseases is anticipated to drive the expansion of the iliac stent market in the foreseeable future. Peripheral artery disease (PAD) is a vascular condition characterized by the narrowing or blockage of arteries outside the heart and brain, often attributed to factors such as smoking, an aging population, hypertension, and diabetes. Iliac stenting emerges as a valuable treatment modality for PAD patients, offering enhanced blood flow, relief from symptoms, and mitigation of complications, all while being minimally invasive and boasting a high success rate. For instance, as per data from the Society for Cardiovascular Angiography and Interventions in July 2023, PAD affects 8-10 million Americans annually, with projections estimating 19 million Americans to be affected by PAD by 2050. Hence, the escalating prevalence of peripheral artery diseases serves as a driving force for the iliac stent market.

Key players in the iliac stent market are dedicated to innovating products such as iCast to elevate patient outcomes and diminish the likelihood of complications. The iCast-covered stent system signifies a novel approach to addressing iliac artery occlusive disease, offering superior performance and a reduced risk of complications compared to conventional bare-metal stents. For instance, in October 2023, Getinge announced the US commercial availability of the iCast-covered stent system, FDA-approved for treating iliac arterial occlusive disease. This development underscores Getinge's commitment to furnishing US clinicians and hospital systems with top-tier products and support for managing this critical condition effectively.

In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems Inc. (CSI) for an undisclosed sum. This strategic move by Abbott Laboratories aims to enrich its vascular device portfolio by integrating CSI's innovative atherectomy system. Cardiovascular Systems Inc. is renowned for its contributions in the realm of medical technology, particularly in manufacturing iliac stents.

Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH

North America was the largest region in the iliac stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the iliac stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iliac Stent Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses iliac stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for iliac stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The iliac stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Self-Expandable Stents; Balloon-Expandable Stents; Other Types
• 2) By Artery Lesions: Common Iliac Artery Lesions; Severe Calcified Lesions
• 3) By End-Users: Hospitals; Outpatient Facilities; Other End-Users
• Subsegments:
• 1) By Self-Expandable Stents: Nitinol Self-Expandable Stents; Polymer-Coated Self-Expandable Stents
• 2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents; Drug-Eluting Balloon-Expandable Stents
• 3) By Other Types: Covered Stents; Hybrid Stents
• Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic Plc; Becton Dickinson and Company; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; W. L. Gore & Associates Inc; C. R. Bard Inc.; Getinge AB; Cook Medical LLC; Biotronik SE & Co. KG; MicroPort Scientific Corporation; Cordis Corporation; Endologix Inc.; LeMaitre Vascular Inc.; Alvimedica; Clearstream Technologies Ltd.; Jotec GmbH; Translumina GmbH; Vascular Concepts Limited; Lombard Medical Technologies; Acandis GmbH; Gore Medical; Medizintechnik GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Iliac Stent Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Iliac Stent Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Iliac Stent Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Iliac Stent Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Minimally Invasive Peripheral Interventions
  • 4.2.2 Increasing Preference For Self-Expandable Iliac Stents
  • 4.2.3 Growing Use Of Drug-Eluting And Covered Stents In Complex Lesions
  • 4.2.4 Shift Toward Outpatient And Day-Care Endovascular Procedures
  • 4.2.5 Expansion Of Iliac Stent Usage In Severe And Calcified Lesions

5. Iliac Stent Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Outpatient Facilities
• 5.3 Ambulatory Surgical Centers
• 5.4 Specialty Cardiology Clinics
• 5.5 Vascular Surgery Centers

6. Iliac Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Iliac Stent Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Iliac Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Iliac Stent Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Iliac Stent Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Iliac Stent Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Iliac Stent Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Iliac Stent Market Segmentation

• 9.1. Global Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Self-Expandable Stents, Balloon-Expandable Stents, Other Types
• 9.2. Global Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Common Iliac Artery Lesions, Severe Calcified Lesions
• 9.3. Global Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Outpatient Facilities, Other End-Users
• 9.4. Global Iliac Stent Market, Sub-Segmentation Of Self-Expandable Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents
• 9.5. Global Iliac Stent Market, Sub-Segmentation Of Balloon-Expandable Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents
• 9.6. Global Iliac Stent Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Covered Stents, Hybrid Stents

10. Iliac Stent Market Regional And Country Analysis

• 10.1. Global Iliac Stent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Iliac Stent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Iliac Stent Market

• 11.1. Asia-Pacific Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Iliac Stent Market

• 12.1. China Iliac Stent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Iliac Stent Market

• 13.1. India Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Iliac Stent Market

• 14.1. Japan Iliac Stent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Iliac Stent Market

• 15.1. Australia Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Iliac Stent Market

• 16.1. Indonesia Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Iliac Stent Market

• 17.1. South Korea Iliac Stent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Iliac Stent Market

• 18.1. Taiwan Iliac Stent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Iliac Stent Market

• 19.1. South East Asia Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Iliac Stent Market

• 20.1. Western Europe Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Iliac Stent Market

• 21.1. UK Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Iliac Stent Market

• 22.1. Germany Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Iliac Stent Market

• 23.1. France Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Iliac Stent Market

• 24.1. Italy Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Iliac Stent Market

• 25.1. Spain Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Iliac Stent Market

• 26.1. Eastern Europe Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Iliac Stent Market

• 27.1. Russia Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Iliac Stent Market

• 28.1. North America Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Iliac Stent Market

• 29.1. USA Iliac Stent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Iliac Stent Market

• 30.1. Canada Iliac Stent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Iliac Stent Market

• 31.1. South America Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Iliac Stent Market

• 32.1. Brazil Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Iliac Stent Market

• 33.1. Middle East Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Iliac Stent Market

• 34.1. Africa Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Iliac Stent Market, Segmentation By Type, Segmentation By Artery Lesions, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Iliac Stent Market Regulatory and Investment Landscape

36. Iliac Stent Market Competitive Landscape And Company Profiles

• 36.1. Iliac Stent Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Iliac Stent Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Iliac Stent Market Company Profiles
  • 36.3.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Iliac Stent Market Other Major And Innovative Companies

• B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH

38. Global Iliac Stent Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Iliac Stent Market

40. Iliac Stent Market High Potential Countries, Segments and Strategies

• 40.1 Iliac Stent Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Iliac Stent Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Iliac Stent Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer